The role of clinical pharmacists in chronic disease management

Review

Bibliographic Data

ID15794829
AuthorsMohammed Ziad Aldaajani (National Guard Health Affairs, corresponding author), Abdulmajeed Awadh Almutairi (National Guard Health Affairs), Abdulmajeed Muhayya Almutairi, Eissa Homuday Almuteriee (National Guard Health Affairs), Abdullah Saleh Abdullah Almorshed (National Guard Health Affairs), Abdullah Saleh Almorshed, Abdullah Abdulrahman Mohammed Alrbian (National Guard Health Affairs), Abdullah Abdulrahman Alrbian, Majed Suliman Alwalie (National Guard Health Affairs), Faleh Mohammed Al Dawsar (National Guard Health Affairs), Manar Ibrahem Alwehaibi (National Guard Health Affairs), Mohammed Mesfer Musaed AL Khathami (National Guard Health Affairs), Norah Mubarak Alomayrah (National Guard Health Affairs), Doaa Ali Alyami (National Guard Health Affairs), Saleh Abdullah Alnais (National Guard Health Affairs), Nuri Rawafa Alanzi (National Guard Health Affairs), Etemad Mohamed Alsharief (National Guard Health Affairs)
Year2024
Volume8
IssueS1
Pages1766-1776
Publication date2024-01-20
Open AccessYes
TypeARTICLE
VenueInternational Journal of Health Sciences (JOURNAL)
Journal identifiersISSN: 2550-696X • E-ISSN: 2550-6978
PublisherUniversidad Tecnica de Manabi (PUBLISHER • EC)
DOI10.53730/ijhs.v8ns1.15389
OpenAlexW4404885179
LanguageEN
References cited36

Background: Chronic diseases, particularly non-communicable diseases (NCDs), are leading causes of morbidity and mortality globally. Effective management of these conditions, such as inflammatory bowel disease (IBD), requires a multidisciplinary approach, including the integration of clinical pharmacists into patient care teams. Methods: This review analyzed literature from seven databases, including MEDLINE and EMBASE, focusing on pharmacist interventions in the management of chronic diseases, specifically type 2 diabetes and asthma, to assess their applicability to IBD. Studies published between 2014 and 2023 were included to evaluate the impact of pharmacist-led initiatives on clinical outcomes. Results: The findings reveal that pharmacist interventions significantly improve patient outcomes in chronic disease management through medication management, patient education, and regular monitoring. While type 2 diabetes and asthma management strategies have been well-documented, there is a notable gap in research regarding pharmacist involvement in IBD care. Proposed interventions for IBD include medication adherence support, risk assessment, and preventive health services, which have demonstrated effectiveness in other chronic conditions. Conclusion: The integration of clinical pharmacists into the management of inflammatory bowel disease presents a valuable opportunity to enhance patient care

Disease · Disease management · Intensive care medicine · Health Systems, Economic Evaluations, Quality of Life · Medicine · Pharmaceutical Practices and Patient Outcomes · Pharmaceutical studies and practices · Internal Medicine

Tools

Open DOIOpen Access